Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Neil Osterweil

    News

    Study supports genetic testing for all breast cancer patients age 65 and younger

    Author:
    Neil Osterweil
    Publish date: March 16, 2020

    Expanding existing genetic testing criteria to all patients age 65 and younger would improve detection of breast...

    • Read More

    News

    Second transplant a good salvage option for children with ALL, AML, or MDS

    Author:
    Neil Osterweil
    Publish date: March 16, 2020

    Patients who had a second hematopoietic stem cell transplant after relapse had sixfold better overall survival...

    • Read More

    News

    Younger children can safely visit HSCT recipients (sometimes)

    Author:
    Neil Osterweil
    Publish date: March 10, 2020

    Children under 12 are welcome – with suitable precautions – to visit patients at some transplant centers, but personae non grata at others.

    • Read More

    News

    Stored CD34 cells for multiple myeloma patients largely unused

    Author:
    Neil Osterweil
    Publish date: March 6, 2020

    ORLANDO – Only 3 of 146 eligible patients actually received a salvage autologous transplant with cells collected...

    • Read More

    News

    No reduction in oral mucositis with folinic acid post transplant

    Author:
    Neil Osterweil
    Publish date: March 3, 2020

    ORLANDO – Folinic acid, a.k.a. leucovorin, offered no benefit for reducing methotrexate-induced oral mucositis in patients receiving GVHD...

    • Read More

    News

    Safer CAR uses modified NK cells for advanced CLL, NHL

    Author:
    Neil Osterweil
    Publish date: February 19, 2020

    Allogeneic CAR-NK cells can be delivered in adoptive transfer without the serious cytokine release syndrome and...

    • Read More

    News

    Adrenal-permissive genotype linked to poor prognosis in prostate cancer

    Author:
    Neil Osterweil
    Publish date: February 13, 2020

    Men with an adrenal-permissive allele of the gene HSD3B1 are at high risk for worse outcomes from advanced prostate cancer.

    • Read More

    News

    Survival for older AML patients better with HSCT from unrelated donors

    Author:
    Neil Osterweil
    Publish date: February 8, 2020

    “Our findings lend support to our hypothesis that a young [matched unrelated donor] should be the donor of choice when available,” reported the...

    • Read More

    News

    Global project reveals cancer’s genomic playbook

    Author:
    Neil Osterweil
    Publish date: February 5, 2020

    The Pan-Cancer Analysis of Whole Genomes, an international collaboration, reveals the complexity of oncogenesis.

    • Read More

    News

    Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumors

    Author:
    Neil Osterweil
    Publish date: January 31, 2020

    Two-thirds of patients with advanced renal cell carcinoma had a clinical response to the TKI/immune checkpoint inhibitor combination.

    • Read More

    News

    High-dose chemo offers survival benefit only for highest-risk breast cancer

    Author:
    Neil Osterweil
    Publish date: January 30, 2020

    Women with 10 or more involved axilliary nodes or triple-negative breast cancer had a 20-year overall survival benefit from high-dose chemotherapy...

    • Read More

    News

    Echoes of SARS mark 2019 novel coronavirus outbreak

    Author:
    Neil Osterweil
    Publish date: January 28, 2020

    One-third of patients hospitalized for 2019 novel coronavirus infection required ICU admission, and six of the 41 (15%) died.

    • Read More

    News

    Adding cannabinoids to opioids doesn’t improve cancer pain control

    Author:
    Neil Osterweil
    Publish date: January 22, 2020

    A systematic review and meta-analysis found no advantage of adjuvant cannabinoids for control of advanced cancer pain.

    • Read More

    News

    Promising early efficacy of venetoclax/navitoclax in r/r acute lymphoblastic leukemia

    Author:
    Neil Osterweil
    Publish date: January 15, 2020

    ORLANDO – Combining the BCL-2 inhibitor venetoclax with low-dose navitoclax produced good response rates in heavily pretreated patients with B-...

    • Read More

    News

    REGN1979 shows good activity in pretreated aggressive B-NHL

    Author:
    Neil Osterweil
    Publish date: January 15, 2020

    The bispecific anti-CD20/CD3 antibody induced complete responses in some heavily pretreated patients,...

    • Read More

    Pages

    • « first
    • …
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery